Cargando…

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?

Alpha-1-antitrypsin deficiency (AATd) is a hereditary disease, mainly characterized by early onset and the lower lobes’ predominant emphysema. Bronchiectasis is characterized by dilatation of the bronchial wall and a clinical syndrome whose features are a cough, sputum production and frequent respir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanduzzi, Alessandro, Ciasullo, Emanuele, Capitelli, Ludovica, Sanduzzi Zamparelli, Stefano, Bocchino, Marialuisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178111/ https://www.ncbi.nlm.nih.gov/pubmed/32235324 http://dx.doi.org/10.3390/ijerph17072294

Ejemplares similares

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

A Phase II Study on the Effect of Taurisolo(®) Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2022)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
por: Mosella, Marco, et al.
Publicado: (2018)

Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
por: Bocchino, Marialuisa, et al.
Publicado: (2021)

Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
por: Pallante, Pierlorenzo, et al.
Publicado: (2021)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis
por: Carreto, Luis, et al.
Publicado: (2020)

CORRELATIONS BETWEEN VIRAL LOAD AND SYMPTOMS IN PATIENTS WITH COVID-19 PNEUMONIA
por: CAPITELLI, L., et al.
Publicado: (2022)

Poor Nutritional Status and Dynapenia Are Highly Prevalent in Post-Acute COVID-19
por: de Blasio, Francesco, et al.
Publicado: (2022)

Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
por: Palladino, Raffaele, et al.
Publicado: (2022)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
por: Stockley, Robert A., et al.
Publicado: (2023)

Psoriatic Disease and Tuberculosis Nowadays
por: Balato, Nicola, et al.
Publicado: (2012)

Subclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fraction
por: D’Andrea, Antonello, et al.
Publicado: (2020)

First Description of the Hyperpnea–Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting
por: Canora, Angelo, et al.
Publicado: (2019)

Dendritic Cells Are the Intriguing Players in the Puzzle of Idiopathic Pulmonary Fibrosis Pathogenesis
por: Bocchino, Marialuisa, et al.
Publicado: (2021)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
por: Buck, Emanuel, et al.
Publicado: (2022)

A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis
por: D’Argenio, Valeria, et al.
Publicado: (2018)

May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence
por: Annunziata, Giuseppe, et al.
Publicado: (2020)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey
por: Tural Onur, Seda, et al.
Publicado: (2023)

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
por: Rodríguez-García, Carlota, et al.
Publicado: (2023)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

Body composition and obstructive sleep apnoea assessment in adult patients with Prader–Willi syndrome: a case control study
por: Pugliese, G., et al.
Publicado: (2022)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Bocchino, Marialuisa, et al.
Publicado: (2010)

Non-Invasive Assessment of Right Ventricle to Arterial Coupling for Prognosis Stratification of Fibrotic Interstitial Lung Diseases
por: Santoro, Ciro, et al.
Publicado: (2022)

Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series
por: Cicchitto, Gaetano, et al.
Publicado: (2022)

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism
por: Milger, Katrin, et al.
Publicado: (2015)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale
por: Ferrarotti, I., et al.
Publicado: (2021)

Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments
por: De Biasi, Sara, et al.
Publicado: (2015)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bk797d0el98uqqe56i0e0d2qu9